company background image
COR logo

Cencora NYSE:COR Stock Report

Last Price

US$235.68

Market Cap

US$46.7b

7D

1.5%

1Y

25.4%

Updated

20 Jun, 2024

Data

Company Financials +

Cencora, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cencora
Historical stock prices
Current Share PriceUS$235.68
52 Week HighUS$246.75
52 Week LowUS$171.65
Beta0.48
11 Month Change8.57%
3 Month Change-2.81%
1 Year Change25.45%
33 Year Change104.09%
5 Year Change175.23%
Change since IPO7,880.70%

Recent News & Updates

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Jun 09
Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

May 21
Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

Recent updates

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Jun 09
Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

May 21
Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Apr 05
Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Cencora Remains Chronically Undervalued, With Material Growth Potential

Mar 25

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Mar 18
Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Feb 25
Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Feb 07
Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Jan 05
Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Jan 04

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Dec 15
A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Nov 05
Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Is Cencora (NYSE:COR) A Risky Investment?

Nov 03
Is Cencora (NYSE:COR) A Risky Investment?

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Oct 18

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

Aug 01
AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Jul 28

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Jun 19
We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

May 01
Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Apr 10
Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet

Mar 02
AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet

AmerisourceBergen declares $0.485 dividend

Feb 01

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Jan 28
AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate

AmerisourceBergen partners with pharmaceutical company Civica

Jan 23

AmerisourceBergen: What Does The Valuation Look Like After The Recent Price Rise?

Jan 13

Does AmerisourceBergen (NYSE:ABC) Deserve A Spot On Your Watchlist?

Jan 10
Does AmerisourceBergen (NYSE:ABC) Deserve A Spot On Your Watchlist?

AmerisourceBergen sued by DoJ over suspicious opioid orders

Dec 29

Walgreens Boots Alliance sells $1.0B in AmerisourceBergen shares; $200M buyback from WBA

Dec 09

Shareholder Returns

CORUS HealthcareUS Market
7D1.5%-1.2%0.4%
1Y25.4%2.3%22.9%

Return vs Industry: COR exceeded the US Healthcare industry which returned 2.4% over the past year.

Return vs Market: COR exceeded the US Market which returned 23.3% over the past year.

Price Volatility

Is COR's price volatile compared to industry and market?
COR volatility
COR Average Weekly Movement2.4%
Healthcare Industry Average Movement6.6%
Market Average Movement5.7%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

Stable Share Price: COR has not had significant price volatility in the past 3 months.

Volatility Over Time: COR's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200144,000Steve Colliswww.cencora.com

Cencora, Inc. sources and distributes pharmaceutical products. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

Cencora, Inc. Fundamentals Summary

How do Cencora's earnings and revenue compare to its market cap?
COR fundamental statistics
Market capUS$46.71b
Earnings (TTM)US$1.85b
Revenue (TTM)US$276.54b

25.1x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
COR income statement (TTM)
RevenueUS$276.54b
Cost of RevenueUS$267.14b
Gross ProfitUS$9.40b
Other ExpensesUS$7.55b
EarningsUS$1.85b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)9.41
Gross Margin3.40%
Net Profit Margin0.67%
Debt/Equity Ratio427.8%

How did COR perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

22%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.